Contributions
Abstract: EP1395
Type: ePoster
Abstract Category: Clinical aspects of MS - Clinical assessment tools
Objective: To examine the risk of depression and anxiety in MS patients in the post-diagnostic period by using clinical screening instruments and a diagnostic structured clinical interview.
Method: From a total population of 470 MS patients, 134 were examined for the risk of depression and anxiety in the post-diagnostic period of MS using the clinical screening instruments Beck Depression Inventory (BDI) and Hospital Anxiety and Depression Scale (HADS). Within six weeks of diagnosis, patients with cut-off >12 for BDI and > 7 for HADS were offered a clinical structured interview using the Schedules for Clinical Assessment in Neuropsychiatry/SCAN Version 2.1. Of the 134 patients, 59 completed the screening phase. Only 29 patients were diagnosed when using the SCAN interview.
Results: The prevalence of depressive symptoms and depression in the post-diagnostic period of MS was 49.2% when using the screening instruments, but only 15.2% when using the SCAN interview. For anxiety, the prevalence was 3.4% for both the screening instruments and the SCAN interview in the post-diagnostic period of MS.
Conclusion: MS patients have a risk of depression and anxiety in the post-diagnostic period of MS, but it is crucial to consider which tools to use in a clinical setting to investigate depression and anxiety in MS patients.
Disclosure:
Huong Hoang: nothing to disclose
Elsebeth Nylev Stenager: nothing to disclose
Egon Stenager: nothing to disclose
Abstract: EP1395
Type: ePoster
Abstract Category: Clinical aspects of MS - Clinical assessment tools
Objective: To examine the risk of depression and anxiety in MS patients in the post-diagnostic period by using clinical screening instruments and a diagnostic structured clinical interview.
Method: From a total population of 470 MS patients, 134 were examined for the risk of depression and anxiety in the post-diagnostic period of MS using the clinical screening instruments Beck Depression Inventory (BDI) and Hospital Anxiety and Depression Scale (HADS). Within six weeks of diagnosis, patients with cut-off >12 for BDI and > 7 for HADS were offered a clinical structured interview using the Schedules for Clinical Assessment in Neuropsychiatry/SCAN Version 2.1. Of the 134 patients, 59 completed the screening phase. Only 29 patients were diagnosed when using the SCAN interview.
Results: The prevalence of depressive symptoms and depression in the post-diagnostic period of MS was 49.2% when using the screening instruments, but only 15.2% when using the SCAN interview. For anxiety, the prevalence was 3.4% for both the screening instruments and the SCAN interview in the post-diagnostic period of MS.
Conclusion: MS patients have a risk of depression and anxiety in the post-diagnostic period of MS, but it is crucial to consider which tools to use in a clinical setting to investigate depression and anxiety in MS patients.
Disclosure:
Huong Hoang: nothing to disclose
Elsebeth Nylev Stenager: nothing to disclose
Egon Stenager: nothing to disclose